BYAH News & Events

Park Ha Biological Technology announced that it has entered into a securities purchase agreement with several investors for the sales of the company's securities in a registered direct offering consisting of up to 1,133,332 of the company's Class A ordinary shares and pre-funded warrants to purchase up to 200,000 Class A ordinary shares, at a combined purchase price of $1.50 per share and pre-funded warrant. The gross proceeds to the company from this offering are expected to be approximately $2M. D. Boral Capital is acting as the sole placement agent for the offering. The company intends to use the net proceeds from this offering for general corporate and working capital purposes.

Park Ha Biological announced that the company has established a partnership with Star Plus Action. The two parties will integrate resources in the healthcare industry, skincare product development, celebrity IP management, and artificial intelligence technology to jointly advance the beauty and wellness sector, creating a business model that combines AI technology, professional skincare services, and health maintenance. Their first collaborative smart product-the AI Nutritionist-has been launched as a pilot. Moving forward, both parties will accelerate the development and deployment of a full-chain intelligent service system, including AI-powered store managers and AI-driven professional skincare specialists, driving the digital transformation of the skincare and wellness industry.

Park Ha Biological Technology Co Ltd trading halted, news pending

Park Ha Biological Technology announced the pricing of a best-efforts follow-on public offering of 21,875,000 units at an offering price of $0.112 per Unit. Each Unit consists of one Class A ordinary share of the Company, par value $0.00002 per share and one warrant to purchase one Class A Ordinary Share. Each Warrant will have an exercise price of $0.112 per Class A Ordinary Share and will be exercisable beginning on the issuance date and ending on the one-year anniversary of the issuance date. The Company expects to receive aggregate gross proceeds of $2.45M from the offering, before deducting placement agent commissions and other estimated expenses payable by the Company, excluding the exercise of any Warrant offered. The offering is expected to close on or about January 28, subject to satisfaction of customary closing conditions. The Company intends to use the net proceeds from this offering for the expansion of directly operated stores in China, and the specific allocation of net proceeds to each market will be based on market conditions. D. Boral Capital is acting as the Sole Placement Agent for the offering.